Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Headshot of Wen-Yi Huang

Wen-Yi Huang, Ph.D., M.S.P.H.

Senior Associate Scientist
Metabolic Epidemiology Branch

NCI Shady Grove

240-276-7277
|
huangw@mail.nih.gov

Biography

GWAS Results: Visualize genome-wide association results with dynamic Manhattan plots and tables.
PLCO Atlas, GWAS Explorer

Interactive access to GWAS data from 110,562 PLCO participants.

Dr. Huang received a Ph.D. in epidemiology from the University of North Carolina at Chapel Hill in 1998, with concentrations on gene-environment interactions and etiologic heterogeneity of breast cancer, defined by molecular markers. She completed two years of postdoctoral research in the Epidemiology Department at Glaxo Wellcome and joined NCI as a staff scientist in DCEG in 2000. Since joining NCI, Dr. Huang has received the NCI DCEG Award for Outstanding Research Paper by a Staff Scientist in 2003, the NIH Award of Merit in 2014, the inaugural NCI DCEG Distinguished Scientific Service Award in 2018, the NCI DCEG Award for Outstanding Research Paper by a Staff Scientist in 2023, and the NCI Staff Scientist and Staff Clinician Outstanding Poster Presentation and Travel Award in 2024. She was promoted to senior associate scientist in 2024.

Research Interests

Dr. Huang provides scientific consultations for nationwide research on cancer etiology and early markers in the NCI Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial; she attends steering, review, and management meetings for the Trial and participates in cohort consortium and data pooling efforts. As a cancer epidemiologist, her studies focus on cancer risk related to genetic, epigenetic, and other molecular markers in DNA repair, metabolic, infection, and inflammation pathways, with primary interests in colorectal and prostate tumors.

Information for Journalists

To request an interview with a DCEG investigator, please complete this form: Request For Comment | HHS.gov.

Email